<DOC>
	<DOCNO>NCT00696215</DOCNO>
	<brief_summary>The objective study assess effect rasagiline cognitive function patient Parkinson 's disease . Patients dopaminergic medication assign receive rasagiline 1 mg placebo 3 month . Cognitive function assess select neuropsychological test represent cognitive domain .</brief_summary>
	<brief_title>The Effects Rasagiline Cognitive Deficits Associated With Parkinson 's Disease</brief_title>
	<detailed_description>The primary objective study assess effect rasagiline cognitive deficit non-demented patient PD . The secondary objective ass affective change patient population . This randomized , double-blind , placebo control study 1-3 center . Patients recruit Movement Disorders Outpatients Clinic , Department Neurology , Istanbul Faculty Medicine , Dokuz Eylul University Marmara University . Eligible patient randomly assign rasagiline 1 mg placebo . Patients treat study medication 3 month . Cognitive behavioral assessment perform baseline , 4 week end study , 12 week . A total 40 PD patient cognitive deficit , without dementia recruit . No sample size calculation perform , sample convenience use .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>1 . Male female patient age 2 . Diagnosis Idiopathic PD accord UK Brain Bank Criteria clinical diagnosis PD . 3 . Patients cognitive impairment associate PD , define : 1 . Subjective complaint impaired cognitive function forgetfulness , word find difficulty inattentiveness 2 . Presence objectively demonstrable cognitive deficit least 2 4 cognitive domain typically impaired PD . These include attention , executive function , memory visuospatial function . The performance follow test score must 1.5 standard deviation mean normative score age education patient : Digit Span attention , Letter Fluency test executive function , Logical Memory Subscale Wechsler Memory ScaleRevised Line Orientation Test visuospatial function . 4 . Patients Hoehn Yahr stage IIII `` '' 5 . Literate patient able follow test instruction 1 . Diagnosis dementia due PD accord DSM IV criteria 2 . Diagnosis current major depressive episode accord DSM IV criteria 3 . Presence neurodegenerative disorder PD 4 . Presence unstable untreated systemic disorder diabetes , cardiac failure , renal failure 5 . Use prohibit concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>rasagiline</keyword>
	<keyword>cognition</keyword>
	<keyword>MAO-B</keyword>
</DOC>